Issues from the FDA Advisory Committee Meeting to Review the New Drug Application (NDA) for the use of Tovaptan to Treat Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Presenter/Facilitator: 

Robin Bechhofer

Date: 
Wednesday, October 2, 2013 - 12:00pm to 1:00pm
Location: 
234 WARF (the red table room)